← Leaderboards
Myron N Williams
Clark Atlanta University
$437,557
Attributed
$437,557
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$437,557 · 2
By mechanism
G12$437,557 · 2
Top collaborators
No co-investigators on record.
Most similar at Clark Atlanta University
Same institution · by research overlap
- Jaideep Chaudhary$6,682,988
- Valerie Odero-Marah$5,958,649
- Paul McGeady$1,264,154
- Kevin Sean Kimbro$9,951,487
- Nathan Maduka Jideama$1,271,184
Others in their field
Top investigators on “Minority Institution Research Support”
- Paula M Mabee · South Dakota Health Technologies Innovations Inc$133,681,131
- Christopher McKay · Battelle Memorial Institute$133,681,131
- Richard Farnsworth · Battelle Memorial Institute$133,681,131
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$114,277,749
- Gregory D Peterson · University Of Tennessee Knoxville$100,231,290
- Richard A Gibbs · Baylor College Of Medicine$83,315,396
Research focus
Minority Institution Research SupportBiological ProductsEnzymesMaleNeoplasm /CancerProteins
Grant awards (6)
MANIPULATION OF RECOMBINANT ANTIBODIES$88,647
G12 · FY2002 · RR
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$88,647
G12 · FY2002 · RR
MANIPULATION OF RECOMBINANT ANTIBODIES$88,647
G12 · FY2001 · RR
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$88,647
G12 · FY2001 · RR
MANIPULATION OF RECOMBINANT ANTIBODIES$60,889
G12 · FY2000 · RR
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS$22,080
G12 · FY2000 · RR